{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T17:16:23Z","timestamp":1769274983735,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["No. 2022YFF0608404"],"award-info":[{"award-number":["No. 2022YFF0608404"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Digit Imaging. Inform. med."],"DOI":"10.1007\/s10278-024-01026-9","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T14:02:34Z","timestamp":1708524154000},"page":"1359-1374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["BTK Expression Level Prediction and the High-Grade Glioma Prognosis Using Radiomic Machine Learning Models"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2673-7008","authenticated-orcid":false,"given":"Chenggang","family":"Jiang","sequence":"first","affiliation":[]},{"given":"Chen","family":"Sun","sequence":"additional","affiliation":[]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Shunchang","family":"Ma","sequence":"additional","affiliation":[]},{"given":"Wang","family":"Jia","sequence":"additional","affiliation":[]},{"given":"Dainan","family":"Zhang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"1026_CR1","doi-asserted-by":"publisher","unstructured":"Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010. Neuro Oncol. 2013;15 Suppl 2(Suppl 2):ii1\u201356. https:\/\/doi.org\/10.1093\/neuonc\/not151","DOI":"10.1093\/neuonc\/not151"},{"key":"1026_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.canlet.2020.02.025","volume":"477","author":"LS Hu","year":"2020","unstructured":"Hu LS, Hawkins-Daarud A, Wang L, Li J, Swanson KR. Imaging of intratumoral heterogeneity in high-grade glioma. Cancer Lett. 2020;477:97-106.https:\/\/doi.org\/10.1016\/j.canlet.2020.02.025","journal-title":"Cancer Lett."},{"key":"1026_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2021.12.008","volume":"527","author":"A Hern\u00e1ndez Mart\u00ednez","year":"2022","unstructured":"Hern\u00e1ndez Mart\u00ednez A, Madurga R, Garc\u00eda-Romero N, Ayuso-Sacido \u00c1. Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing. Cancer Lett. 2022;527:66-79. https:\/\/doi.org\/10.1016\/j.canlet.2021.12.008","journal-title":"Cancer Lett."},{"key":"1026_CR4","doi-asserted-by":"publisher","first-page":"15017","DOI":"10.1038\/nrdp.2015.17","volume":"1","author":"M Weller","year":"2015","unstructured":"Weller M, Wick W, Aldape K, et al. Glioma. Nat Rev Dis Primers. 2015;1:15017.https:\/\/doi.org\/10.1038\/nrdp.2015.17","journal-title":"Glioma. Nat Rev Dis Primers."},{"issue":"6","key":"1026_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803-820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol."},{"issue":"4","key":"1026_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11912-017-0585-6","volume":"19","author":"NAO Bush","year":"2017","unstructured":"Bush NAO, Butowski N. The Effect of Molecular Diagnostics on the Treatment of Glioma. Curr Oncol Rep. 2017;19(4):26. https:\/\/doi.org\/10.1007\/s11912-017-0585-6","journal-title":"Curr Oncol Rep."},{"issue":"10","key":"1026_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/jnnp-2020-325334","volume":"92","author":"R Ma","year":"2021","unstructured":"Ma R, Taphoorn MJB, Plaha P. Advances in the management of glioblastoma. J Neurol Neurosurg Psychiatry. 2021;92(10):1103-1111. https:\/\/doi.org\/10.1136\/jnnp-2020-325334","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"7","key":"1026_CR8","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrclinonc.2016.204","volume":"14","author":"G Reifenberger","year":"2017","unstructured":"Reifenberger G, Wirsching HG, Knobbe-Thomsen CB, Weller M. Advances in the molecular genetics of gliomas - implications for classification and therapy. Nat Rev Clin Oncol. 2017;14(7):434-452. https:\/\/doi.org\/10.1038\/nrclinonc.2016.204","journal-title":"Nat Rev Clin Oncol."},{"issue":"2","key":"1026_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110216","volume":"38","author":"T Qin","year":"2022","unstructured":"Qin T, Mullan B, Ravindran R, et al. ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization. Cell Rep. 2022;38(2):110216.\u00a0https:\/\/doi.org\/10.1016\/j.celrep.2021.110216","journal-title":"Cell Rep."},{"issue":"3","key":"1026_CR10","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/neuonc\/now189","volume":"19","author":"HN Nguyen","year":"2017","unstructured":"Nguyen HN, Lie A, Li T, et al. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro Oncol. 2017;19(3):394-404.\u00a0https:\/\/doi.org\/10.1093\/neuonc\/now189","journal-title":"Neuro Oncol."},{"issue":"2","key":"1026_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/biomedicines10020246","volume":"10","author":"LE Huang","year":"2022","unstructured":"Huang LE. Impact of CDKN2A\/B Homozygous Deletion on the Prognosis and Biology of IDH-Mutant Glioma. Biomedicines. 2022;10(2):246. https:\/\/doi.org\/10.3390\/biomedicines10020246","journal-title":"Biomedicines."},{"issue":"2","key":"1026_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00401-018-1837-8","volume":"136","author":"A Reinhardt","year":"2018","unstructured":"Reinhardt A, Stichel D, Schrimpf D, et al. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A\/B and ATRX alterations. Acta Neuropathol. 2018;136(2):273-291.\u00a0https:\/\/doi.org\/10.1007\/s00401-018-1837-8","journal-title":"Acta Neuropathol."},{"key":"1026_CR13","doi-asserted-by":"publisher","unstructured":"E CC, J C. Bruton\u2019s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis. Expert opinion on emerging drugs. 2020;25(4).\u00a0https:\/\/doi.org\/10.1080\/14728214.2020.1822817","DOI":"10.1080\/14728214.2020.1822817"},{"issue":"1","key":"1026_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa1215637","volume":"369","author":"JC Byrd","year":"2013","unstructured":"Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369(1):32-42.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa1215637","journal-title":"N Engl J Med."},{"issue":"3","key":"1026_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nrc.2017.121","volume":"18","author":"JA Burger","year":"2018","unstructured":"Burger JA, Wiestner A. Targeting B cell receptor signalling in cancer: preclinical and clinical advances. Nat Rev Cancer. 2018;18(3):148-167.\u00a0https:\/\/doi.org\/10.1038\/nrc.2017.121","journal-title":"Nat Rev Cancer."},{"issue":"15","key":"1026_CR16","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-19-2856","volume":"26","author":"JC Byrd","year":"2020","unstructured":"Byrd JC, Furman RR, Coutre SE, et al. Ibrutinib Treatment for First-Line and Relapsed\/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib\/II PCYC-1102 Study. Clin Cancer Res. 2020;26(15):3918-3927.\u00a0https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2856","journal-title":"Clin Cancer Res."},{"issue":"23","key":"1026_CR17","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1182\/blood.2021011787","volume":"138","author":"M Butler","year":"2021","unstructured":"Butler M, van Ingen Schenau DS, Yu J, et al. BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway. Blood. 2021;138(23):2383-2395. https:\/\/doi.org\/10.1182\/blood.2021011787","journal-title":"Blood."},{"issue":"13","key":"1026_CR18","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMoa1715519","volume":"378","author":"CS Tam","year":"2018","unstructured":"Tam CS, Anderson MA, Pott C, et al. Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma. N Engl J Med. 2018;378(13):1211-1223.\u00a0https:\/\/doi.org\/10.1056\/NEJMoa1715519","journal-title":"N Engl J Med."},{"issue":"2","key":"1026_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/path.5347","volume":"250","author":"M Lavitrano","year":"2020","unstructured":"Lavitrano M, Ianzano L, Bonomo S, et al. BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers. J Pathol. 2020;250(2):134-147.\u00a0https:\/\/doi.org\/10.1002\/path.5347","journal-title":"J Pathol."},{"issue":"7","key":"1026_CR20","first-page":"3003","volume":"8","author":"JD Wang","year":"2016","unstructured":"Wang JD, Chen XY, Ji KW, Tao F. Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth. Am J Transl Res. 2016;8(7):3003-3012.","journal-title":"Am J Transl Res."},{"issue":"5","key":"1026_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3892\/or.2021.8007","volume":"45","author":"JM Kim","year":"2021","unstructured":"Kim JM, Park J, Noh EM, et al. Bruton\u2019s agammaglobulinemia tyrosine kinase (Btk) regulates TPA\u2011induced breast cancer cell invasion via PLC\u03b32\/PKC\u03b2\/NF\u2011\u03baB\/AP\u20111\u2011dependent matrix metalloproteinase\u20119 activation. Oncol Rep. 2021;45(5):56. https:\/\/doi.org\/10.3892\/or.2021.8007","journal-title":"Oncol Rep."},{"issue":"1","key":"1026_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13046-017-0600-7","volume":"36","author":"C Yue","year":"2017","unstructured":"Yue C, Niu M, Shan QQ, et al. High expression of Bruton\u2019s tyrosine kinase (BTK) is required for EGFR-induced NF-\u03baB activation and predicts poor prognosis in human glioma. J Exp Clin Cancer Res. 2017;36(1):132. https:\/\/doi.org\/10.1186\/s13046-017-0600-7","journal-title":"J Exp Clin Cancer Res."},{"issue":"24","key":"1026_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.146362","volume":"6","author":"H Yang","year":"2021","unstructured":"Yang H, Liu X, Zhu X, et al. CPVL promotes glioma progression via STAT1 pathway inhibition through interactions with the BTK\/p300 axis. JCI Insight. 2021;6(24):e146362. https:\/\/doi.org\/10.1172\/jci.insight.146362","journal-title":"JCI Insight."},{"issue":"9","key":"1026_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3390\/ph14090876","volume":"14","author":"YK Su","year":"2021","unstructured":"Su YK, Bamodu OA, Su IC, et al. Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK\/mTOR\/VEGF Signaling. Pharmaceuticals (Basel). 2021;14(9):876. https:\/\/doi.org\/10.3390\/ph14090876","journal-title":"Pharmaceuticals (Basel)."},{"key":"1026_CR25","doi-asserted-by":"publisher","unstructured":"Rt L, G D, D DR, P L, W van E. Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures. The British journal of radiology. 2017;90(1070). https:\/\/doi.org\/10.1259\/bjr.20160665","DOI":"10.1259\/bjr.20160665"},{"issue":"1061","key":"1026_CR26","doi-asserted-by":"publisher","first-page":"20151030","DOI":"10.1259\/bjr.20151030","volume":"89","author":"HX Bai","year":"2016","unstructured":"Bai HX, Lee AM, Yang L, et al. Imaging genomics in cancer research: limitations and promises. Br J Radiol. 2016;89(1061):20151030. https:\/\/doi.org\/10.1259\/bjr.20151030","journal-title":"Br J Radiol."},{"issue":"7","key":"1026_CR27","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.3390\/cancers14071778","volume":"14","author":"Y Li","year":"2022","unstructured":"Li Y, Ammari S, Lawrance L, et al. Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p\/19q Codeletion. Cancers (Basel). 2022;14(7):1778. https:\/\/doi.org\/10.3390\/cancers14071778","journal-title":"Cancers (Basel)."},{"key":"1026_CR28","doi-asserted-by":"publisher","first-page":"4630218","DOI":"10.1155\/2020\/4630218","volume":"2020","author":"L Niu","year":"2020","unstructured":"Niu L, Feng WH, Duan CF, Liu YC, Liu JH, Liu XJ. The Value of Enhanced MR Radiomics in Estimating the IDH1 Genotype in High-Grade Gliomas. Biomed Res Int. 2020;2020:4630218. https:\/\/doi.org\/10.1155\/2020\/4630218","journal-title":"Biomed Res Int."},{"key":"1026_CR29","doi-asserted-by":"publisher","unstructured":"Y T, W M, Xc W, Gq Y, Rj G, H Z. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors. European journal of radiology. 2019;120. https:\/\/doi.org\/10.1016\/j.ejrad.2019.07.010","DOI":"10.1016\/j.ejrad.2019.07.010"},{"issue":"1","key":"1026_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3174\/ajnr.A6365","volume":"41","author":"W Han","year":"2020","unstructured":"Han W, Qin L, Bay C, et al. Deep Transfer Learning and Radiomics Feature Prediction of Survival of Patients with High-Grade Gliomas. AJNR Am J Neuroradiol. 2020;41(1):40-48. https:\/\/doi.org\/10.3174\/ajnr.A6365","journal-title":"AJNR Am J Neuroradiol."},{"issue":"1","key":"1026_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/jmri.25896","volume":"48","author":"W Rui","year":"2018","unstructured":"Rui W, Ren Y, Wang Y, Gao X, Xu X, Yao Z. MR textural analysis on T2 FLAIR images for the prediction of true oligodendroglioma by the 2016 WHO genetic classification. J Magn Reson Imaging. 2018;48(1):74-83. https:\/\/doi.org\/10.1002\/jmri.25896","journal-title":"J Magn Reson Imaging."},{"key":"1026_CR32","doi-asserted-by":"publisher","unstructured":"Liu X, Li Y, Qian Z, et al. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas. NeuroImage: Clinical. 2018;20:1070\u20131077. https:\/\/doi.org\/10.1016\/j.nicl.2018.10.014","DOI":"10.1016\/j.nicl.2018.10.014"},{"issue":"1","key":"1026_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang KN, Wang Q, et al. Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients. Genomics, Proteomics & Bioinformatics. 2021;19(1):1-12. https:\/\/doi.org\/10.1016\/j.gpb.2020.10.005","journal-title":"Genomics, Proteomics & Bioinformatics."},{"issue":"10","key":"1026_CR34","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.20892\/j.issn.2095-3941.2022.0469","volume":"19","author":"K Zhang","year":"2022","unstructured":"Zhang K, Liu X, Li G, et al. Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011\u20132017): a multicenter retrospective study from CGGA. Cancer Biology & Medicine. 2022;19(10):1460-1476. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0469","journal-title":"Cancer Biology & Medicine."},{"issue":"2","key":"1026_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/neuonc\/nou130","volume":"17","author":"Y Wang","year":"2015","unstructured":"Wang Y, Qian T, You G, et al. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping. Neuro-Oncology. 2015;17(2):282-288. https:\/\/doi.org\/10.1093\/neuonc\/nou130","journal-title":"Neuro-Oncology."},{"issue":"4","key":"1026_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G, et al. Introduction to Radiomics. J Nucl Med. 2020;61(4):488-495. https:\/\/doi.org\/10.2967\/jnumed.118.222893","journal-title":"J Nucl Med."},{"issue":"1","key":"1026_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, et al. From Local Explanations to Global Understanding with Explainable AI for Trees. Nat Mach Intell. 2020;2(1):56-67. https:\/\/doi.org\/10.1038\/s42256-019-0138-9","journal-title":"Nat Mach Intell."},{"key":"1026_CR38","doi-asserted-by":"crossref","unstructured":"He K, Zhang X, Ren S, Sun J. Deep Residual Learning for Image Recognition. In: ; 2016:770\u2013778. Accessed January 16, 2024. https:\/\/openaccess.thecvf.com\/content_cvpr_2016\/html\/He_Deep_Residual_Learning_CVPR_2016_paper.html","DOI":"10.1109\/CVPR.2016.90"},{"issue":"3","key":"1026_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11263-015-0816-y","volume":"115","author":"O Russakovsky","year":"2015","unstructured":"Russakovsky O, Deng J, Su H, et al. ImageNet Large Scale Visual Recognition Challenge. Int J Comput Vis. 2015;115(3):211-252. https:\/\/doi.org\/10.1007\/s11263-015-0816-y","journal-title":"Int J Comput Vis."},{"key":"1026_CR40","doi-asserted-by":"publisher","unstructured":"Simonyan K, Zisserman A. Very Deep Convolutional Networks for Large-Scale Image Recognition. Published online April 10, 2015. https:\/\/doi.org\/10.48550\/arXiv.1409.1556","DOI":"10.48550\/arXiv.1409.1556"},{"issue":"7","key":"1026_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37(7):773-782. https:\/\/doi.org\/10.1038\/s41587-019-0114-2","journal-title":"Nat Biotechnol."},{"issue":"10145","key":"1026_CR42","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(18)30990-5","volume":"392","author":"S Lapointe","year":"2018","unstructured":"Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet. 2018;392(10145):432-446. https:\/\/doi.org\/10.1016\/S0140-6736(18)30990-5","journal-title":"Lancet."},{"key":"1026_CR43","doi-asserted-by":"publisher","unstructured":"Jp F, Dc A. Current FDA-Approved Therapies for High-Grade Malignant Gliomas. Biomedicines. 2021;9(3). https:\/\/doi.org\/10.3390\/biomedicines9030324","DOI":"10.3390\/biomedicines9030324"},{"issue":"2","key":"1026_CR44","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4143\/crt.2019.242","volume":"52","author":"Q Wang","year":"2020","unstructured":"Wang Q, Xiao F, Qi F, Song X, Yu Y. Risk Factors for Cognitive Impairment in High-Grade Glioma Patients Treated with Postoperative Radiochemotherapy. Cancer Res Treat. 2020;52(2):586-593. https:\/\/doi.org\/10.4143\/crt.2019.242","journal-title":"Cancer Res Treat."},{"key":"1026_CR45","doi-asserted-by":"publisher","unstructured":"Kudus K, Wagner MW, Namdar K, et al. Increased confidence of radiomics facilitating pretherapeutic differentiation of BRAF-altered pediatric low-grade glioma. Eur Radiol. Published online October 7, 2023. https:\/\/doi.org\/10.1007\/s00330-023-10267-1","DOI":"10.1007\/s00330-023-10267-1"},{"key":"1026_CR46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mri.2023.09.001","volume":"104","author":"J Lu","year":"2023","unstructured":"Lu J, Xu W, Chen X, Wang T, Li H. Noninvasive prediction of IDH mutation status in gliomas using preoperative multiparametric MRI radiomics nomogram: A mutlicenter study. Magn Reson Imaging. 2023;104:72-79. https:\/\/doi.org\/10.1016\/j.mri.2023.09.001","journal-title":"Magn Reson Imaging."},{"issue":"18","key":"1026_CR47","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/cancers15184661","volume":"15","author":"Z Wu","year":"2023","unstructured":"Wu Z, Yang Y, Zha Y. Radiomics Features on Magnetic Resonance Images Can Predict C5aR1 Expression Levels and Prognosis in High-Grade Glioma. Cancers (Basel). 2023;15(18):4661. https:\/\/doi.org\/10.3390\/cancers15184661","journal-title":"Cancers (Basel)."},{"issue":"12","key":"1026_CR48","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/bjc.2011.177","volume":"104","author":"GK Schwartz","year":"2011","unstructured":"Schwartz GK, LoRusso PM, Dickson MA, et al. Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2\/1). Br J Cancer. 2011;104(12):1862-1868. https:\/\/doi.org\/10.1038\/bjc.2011.177","journal-title":"Br J Cancer."},{"issue":"4","key":"1026_CR49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa2211582","volume":"388","author":"JR Brown","year":"2023","unstructured":"Brown JR, Eichhorst B, Hillmen P, et al. Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. N Engl J Med. 2023;388(4):319-332. https:\/\/doi.org\/10.1056\/NEJMoa2211582","journal-title":"N Engl J Med."},{"issue":"9","key":"1026_CR50","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","volume":"19","author":"R Sun","year":"2018","unstructured":"Sun R, Limkin EJ, Vakalopoulou M, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol. 2018;19(9):1180-1191. https:\/\/doi.org\/10.1016\/S1470-2045(18)30413-3","journal-title":"Lancet Oncol."},{"key":"1026_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109036","volume":"110","author":"H Guo","year":"2022","unstructured":"Guo H, Xie M, Liu W, et al. Inhibition of BTK improved APAP-induced liver injury via suppressing proinflammatory macrophages activation by restoring mitochondrion function. Int Immunopharmacol. 2022;110:109036. https:\/\/doi.org\/10.1016\/j.intimp.2022.109036","journal-title":"Int Immunopharmacol."},{"issue":"2","key":"1026_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/08830185.2012.664797","volume":"31","author":"JJ Buggy","year":"2012","unstructured":"Buggy JJ, Elias L. Bruton tyrosine kinase (BTK) and its role in B-cell malignancy. Int Rev Immunol. 2012;31(2):119-132. https:\/\/doi.org\/10.3109\/08830185.2012.664797","journal-title":"Int Rev Immunol."},{"key":"1026_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109941","volume":"144","author":"W Shi","year":"2021","unstructured":"Shi W, Qu C, Wang X, Liang X, Tan Y, Zhang H. Diffusion kurtosis imaging combined with dynamic susceptibility contrast-enhanced MRI in differentiating high-grade glioma recurrence from pseudoprogression. Eur J Radiol. 2021;144:109941. https:\/\/doi.org\/10.1016\/j.ejrad.2021.109941","journal-title":"Eur J Radiol."},{"key":"1026_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.957795","volume":"16","author":"Z Shi","year":"2022","unstructured":"Shi Z, Jiang J, Xie L, Zhao X. Efficacy evaluation of contrast-enhanced magnetic resonance imaging in differentiating glioma from metastatic tumor of the brain and exploration of its association with patients\u2019 neurological function. Front Behav Neurosci. 2022;16:957795. https:\/\/doi.org\/10.3389\/fnbeh.2022.957795","journal-title":"Front Behav Neurosci."},{"issue":"12","key":"1026_CR55","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.3390\/jcm11123445","volume":"11","author":"S Chen","year":"2022","unstructured":"Chen S, Xu Y, Ye M, et al. Predicting MGMT Promoter Methylation in Diffuse Gliomas Using Deep Learning with Radiomics. J Clin Med. 2022;11(12):3445. https:\/\/doi.org\/10.3390\/jcm11123445","journal-title":"J Clin Med."},{"issue":"2","key":"1026_CR56","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/neuonc\/noaa190","volume":"23","author":"L Joo","year":"2021","unstructured":"Joo L, Park JE, Park SY, et al. Extensive peritumoral edema and brain-to-tumor interface MRI features enable prediction of brain invasion in meningioma: development and validation. Neuro Oncol. 2021;23(2):324-333. https:\/\/doi.org\/10.1093\/neuonc\/noaa190","journal-title":"Neuro Oncol."},{"issue":"9","key":"1026_CR57","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1007\/s00330-022-08685-8","volume":"32","author":"AJ Vickers","year":"2022","unstructured":"Vickers AJ, Woo S. Decision curve analysis in the evaluation of radiology research. Eur Radiol. 2022;32(9):5787-5789. https:\/\/doi.org\/10.1007\/s00330-022-08685-8","journal-title":"Eur Radiol."},{"issue":"6440","key":"1026_CR58","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1126\/science.aav7062","volume":"364","author":"D Sugiura","year":"2019","unstructured":"Sugiura D, Maruhashi T, Okazaki IM, et al. Restriction of PD-1 function by cis-PD-L1\/CD80 interactions is required for optimal T cell responses. Science. 2019;364(6440):558-566. https:\/\/doi.org\/10.1126\/science.aav7062","journal-title":"Science."},{"issue":"9","key":"1026_CR59","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2021.04.011","volume":"28","author":"Y Li","year":"2021","unstructured":"Li Y, Jia L, Kim JK, et al. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance. Cell Stem Cell. 2021;28(9):1597-1613.e7. https:\/\/doi.org\/10.1016\/j.stem.2021.04.011","journal-title":"Cell Stem Cell."},{"key":"1026_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.654960","volume":"12","author":"Z Ning","year":"2021","unstructured":"Ning Z, Liu K, Xiong H. Roles of BTLA in Immunity and Immune Disorders. Front Immunol. 2021;12:654960. https:\/\/doi.org\/10.3389\/fimmu.2021.654960","journal-title":"Front Immunol."}],"container-title":["Journal of Imaging Informatics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01026-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10278-024-01026-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10278-024-01026-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T17:08:59Z","timestamp":1722877739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10278-024-01026-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1007\/s10278-024-01026-9","relation":{},"ISSN":["2948-2933"],"issn-type":[{"value":"2948-2933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animal, human, and potentially identifiable human images or data studies are presented in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors agreed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}